News
-
-
-
COMMUNIQUÉ DE PRESSE
Ondine Biomedical Inc. - Economic Study Suggests c.£200 Million UK Savings
YHEC study shows Steriwave technology could save UK hospitals £200 million annually by reducing surgical site infections. CEO Carolyn Cross emphasizes importance of infection prevention and cost containment -
-
-
COMMUNIQUÉ DE PRESSE
CORRECTION: Ondine Biomedical Inc. Announces Steriwave in first Swiss hospital
University Hospital Zurich initiates independent clinical study on Ondine Biomedical's Steriwave for preoperative nasal decolonization, led by Professor Dr. Dr. Harald Essig, to combat surgical site infections -
-
-
-